Dr. Bertrand Tombal delivered a practical presentation titled “What Do You Need for Decision Making in mHSPC in 2026?”, focusing on how contemporary therapeutic choices in metastatic hormone-sensitive ...

European Union officials say they have offered money and technical help to Ukraine to fix a key oil pipeline to central Europe. They hope that will persuade Hungary to drop ...

The market for radioligand therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by ...

Hormone therapy use and duration with post-operative radiotherapy for recurrent prostate cancer: An individual patient data meta-analysis. This is an ASCO Meeting Abstract from the 2026 ASCO ...

The impact of rising PSA during salvage radiotherapy post radical prostatectomy on relapse. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This abstract does not ...

NEW YORK, Feb 23 (Reuters) – Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar drug cuts the risk of death from prostate cancer ...

Small fragments of plastic were found in 9 out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, single-center ...

Tomorrow week, Sarah Keane will finally settle into her work as chief executive of Cricket Ireland. Having been appointed in October, the former Swim Ireland CEO has been working a couple of days a ...

Over the past decade or so, prostate-specific membrane antigen (PSMA) PET/CT has increasingly replaced conventional imaging in men with biochemical recurrence after radical prostatectomy. PSMA PET/CT ...